KRAS and non-small cell lung carcinoma: The enhanced K-Ras signaling also promotes glycolysis and metastasis pathways (Ying et al, 2012; Cox et al, 2014; Gorfe & Cho, 2019), further stimulating the antioxidant/BACH1/glycolysis-induced NSCLC metastasis (Fig 6).